Cloxacillin Macure: Uses, Dosage & Side Effects

What Is Cloxacillin Macure and What Is It Used For?

Cloxacillin Macure contains the active substance cloxacillin (in the form of cloxacillin sodium), which belongs to the isoxazolyl penicillin subclass of beta-lactam antibiotics. The isoxazolyl penicillins were developed in the early 1960s specifically to address the growing problem of staphylococcal resistance to standard penicillin. The key chemical modification involves the addition of an isoxazolyl side chain to the penicillin nucleus, which provides steric protection against hydrolysis by staphylococcal penicillinase.

The mechanism of action of cloxacillin is fundamentally the same as all beta-lactam antibiotics. It inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), which are enzymes responsible for the final transpeptidation step in peptidoglycan biosynthesis. Without a functional cell wall, bacteria are unable to maintain their osmotic integrity, leading to cell lysis and death. What makes cloxacillin particularly valuable is its resistance to the beta-lactamase enzyme produced by many staphylococcal species. Standard penicillin G is rapidly hydrolyzed by this enzyme, rendering it ineffective against penicillinase-producing strains.

Cloxacillin Macure is indicated for the treatment of infections caused by penicillinase-producing staphylococci, including:

• Skin and soft tissue infections — cellulitis, wound infections, abscesses, impetigo, and infected surgical wounds caused by MSSA
• Bone and joint infections — osteomyelitis and septic arthritis, where cloxacillin is often the first-line treatment for MSSA-related disease
• Endocarditis — infection of the heart valves, particularly native valve endocarditis caused by MSSA, often in combination with an aminoglycoside for synergistic bactericidal activity
• Septicemia — bloodstream infections (bacteremia) caused by susceptible staphylococci
• Respiratory tract infections — pneumonia and other lower respiratory tract infections when caused by penicillinase-producing staphylococci

It is important to understand that cloxacillin has a relatively narrow spectrum of antimicrobial activity. While it excels against penicillinase-producing staphylococci, it has limited activity against streptococci (where standard penicillin is preferred) and essentially no activity against gram-negative organisms, enterococci, or methicillin-resistant Staphylococcus aureus (MRSA). For this reason, culture and susceptibility testing should ideally be performed before initiating treatment, and empirical therapy should be guided by local resistance patterns.

According to the Infectious Diseases Society of America (IDSA) guidelines and European Society of Clinical Microbiology and Infectious Diseases (ESCMID) recommendations, anti-staphylococcal penicillins such as cloxacillin remain the gold standard for treating MSSA infections. Multiple studies have demonstrated that outcomes in MSSA bacteremia are superior when patients receive a penicillinase-resistant penicillin (such as cloxacillin or flucloxacillin) compared to broader-spectrum alternatives like vancomycin or cephalosporins.

What Should You Know Before Taking Cloxacillin Macure?

Contraindications

Cloxacillin Macure is contraindicated (must not be used) in patients with:

• Known hypersensitivity to penicillins — A confirmed allergy to any penicillin-type antibiotic is an absolute contraindication. Allergic reactions to penicillins can range from mild skin rashes to life-threatening anaphylaxis. If you have ever experienced hives, swelling of the face or throat, difficulty breathing, or anaphylaxis after taking any penicillin antibiotic, you must not receive cloxacillin.
• History of severe allergic reaction to other beta-lactams — While the cross-reactivity rate between penicillins and cephalosporins is estimated at 1-10%, patients who have experienced severe or immediate-type allergic reactions (anaphylaxis, angioedema) to any beta-lactam antibiotic should generally avoid cloxacillin unless penicillin allergy has been formally excluded through allergy testing.

Warnings and Precautions

Your healthcare provider should be informed of the following conditions before you receive Cloxacillin Macure:

• Liver disease or impairment — Cloxacillin is partially metabolized by the liver. Hepatotoxicity, including cholestatic jaundice and hepatitis, has been reported with isoxazolyl penicillins. Liver function should be monitored during prolonged therapy, particularly in patients with pre-existing hepatic disease. The risk of hepatotoxicity may be increased in elderly patients and those receiving high doses.
• Kidney disease or impairment — Cloxacillin is primarily excreted through the kidneys. In patients with significant renal impairment, drug accumulation may occur, potentially increasing the risk of adverse effects including neurotoxicity. Dose adjustment may be necessary in patients with severe renal impairment (creatinine clearance less than 10 mL/min).
• History of gastrointestinal disease — As with all antibiotics, cloxacillin may disrupt normal intestinal flora and lead to overgrowth of Clostridioides difficile, potentially causing pseudomembranous colitis. This condition can range from mild to life-threatening and may occur during or after antibiotic therapy.
• Sodium content — Cloxacillin Macure powder for injection contains sodium. Each 1 g vial contains approximately 2.2 mmol (approximately 50 mg) of sodium. This should be considered in patients on sodium-restricted diets, such as those with heart failure, hypertension, or kidney disease.
• Prolonged use — Extended treatment may result in the overgrowth of non-susceptible organisms, including fungi. Regular monitoring of organ function, including hepatic, renal, and hematopoietic function, is recommended during prolonged therapy.

Pregnancy and Breastfeeding

Penicillins as a class are generally considered among the safest antibiotics during pregnancy and have been used extensively without evidence of significant teratogenic effects. Cloxacillin crosses the placenta and reaches the fetal circulation, but reproductive studies in animals have not demonstrated evidence of harm to the fetus. Nevertheless, it should be used during pregnancy only when clearly needed and when the potential benefit justifies the potential risk.

Cloxacillin is excreted in small amounts in breast milk. While the concentrations in breast milk are generally too low to cause systemic effects in the nursing infant, there is a theoretical risk of sensitization (allergic sensitization to penicillins), diarrhea, or candidiasis in the breastfed infant. The decision to breastfeed during cloxacillin therapy should be made in consultation with your healthcare provider, weighing the benefits of breastfeeding against the potential risks to the infant.

How Does Cloxacillin Macure Interact with Other Drugs?

Drug interactions with cloxacillin can affect the efficacy and safety of both cloxacillin and the co-administered medications. The following interactions are clinically significant and require awareness by both healthcare professionals and patients. Always inform your doctor about all medications you are taking, including prescription drugs, over-the-counter medicines, vitamins, and herbal supplements.

Major Interactions

Other Interactions

• Oral contraceptives — Although the clinical significance remains debated, antibiotics including cloxacillin may theoretically reduce the effectiveness of oral contraceptive pills by disrupting enterohepatic recirculation of estrogens. Additional contraceptive precautions may be advisable during cloxacillin therapy and for 7 days after completion.
• Tetracyclines and chloramphenicol — Bacteriostatic antibiotics such as tetracyclines and chloramphenicol may antagonize the bactericidal activity of penicillins. Co-administration should generally be avoided unless specifically directed by an infectious disease specialist.
• Aminoglycosides — While synergistic bactericidal activity between penicillins and aminoglycosides is often therapeutically desirable (particularly in endocarditis), these agents should not be mixed in the same intravenous solution as they are physically and chemically incompatible, leading to mutual inactivation.
• Allopurinol — Co-administration with allopurinol may increase the incidence of skin rashes, though this interaction is better documented with ampicillin and amoxicillin than with cloxacillin.
• Laboratory test interference — Cloxacillin may cause false-positive results in urinary glucose tests that use copper reduction methods (such as Benedict's solution or Clinitest). Enzymatic glucose oxidase methods (such as Clinistix) are not affected and should be used instead.

What Is the Correct Dosage of Cloxacillin Macure?

Cloxacillin Macure is available as a powder for solution for injection or infusion. The powder must be reconstituted with a suitable diluent (such as sterile water for injection or sodium chloride 0.9%) before administration. The reconstituted solution can be administered by slow intravenous injection (over 3–5 minutes), intravenous infusion (over 30–60 minutes), or intramuscular injection. The dosage and route of administration depend on the type, severity, and location of the infection, as well as the patient's age, weight, and renal function.

Adults

Children

Elderly

Missed Dose

Since Cloxacillin Macure is administered in a hospital or clinical setting by healthcare professionals, missed doses are uncommon. However, if a dose is missed or delayed, it should be given as soon as possible. It is important to maintain consistent dosing intervals to ensure adequate blood levels of the antibiotic throughout the treatment course. Time-dependent killing is the key pharmacodynamic property of beta-lactam antibiotics, meaning that the time the drug concentration remains above the minimum inhibitory concentration (MIC) of the pathogen is the primary determinant of efficacy. For this reason, maintaining regular dosing intervals is critical for treatment success.

Overdose

Overdose with cloxacillin is uncommon given its parenteral route of administration in controlled healthcare settings. However, excessively high doses of penicillins can cause neurotoxicity, manifesting as encephalopathy, seizures, myoclonus, and altered consciousness. This risk is particularly elevated in patients with renal impairment, where drug accumulation may occur. Treatment of overdose is primarily supportive, with maintenance of adequate hydration and monitoring of renal and hepatic function. Cloxacillin is not effectively removed by hemodialysis due to its high protein binding (approximately 94–96%).

What Are the Side Effects of Cloxacillin Macure?

Like all medications, Cloxacillin Macure can cause side effects, although not everyone experiences them. The side effects listed below are categorized by their frequency of occurrence according to the standard medical convention used in the European Union Summary of Product Characteristics (SmPC). Understanding the frequency classification helps patients and healthcare providers weigh the risks and benefits of treatment.

Many of the side effects associated with cloxacillin are common to the penicillin class as a whole and are related to the drug's effects on the immune system (hypersensitivity) or on the body's normal bacterial flora (gastrointestinal disturbances). Some side effects, particularly hepatotoxicity, appear to be more specifically associated with the isoxazolyl penicillin subgroup.

Hepatotoxicity deserves special attention with isoxazolyl penicillins. Cholestatic hepatitis has been reported, usually developing within the first few weeks of treatment or shortly after discontinuation. Risk factors include older age (over 55 years), prolonged treatment duration (greater than 14 days), and high doses. In most cases, hepatic injury is reversible upon discontinuation of the drug, although recovery may take several weeks to months. Fulminant hepatic failure has been reported in very rare cases, primarily with the closely related drug flucloxacillin.

Injection site reactions are common with intravenous administration. Phlebitis (inflammation of the vein) can be minimized by ensuring adequate dilution of the drug, using large veins for infusion, and rotating injection sites. If significant pain or signs of extravasation occur, the infusion should be stopped and restarted at a different site.

How Should You Store Cloxacillin Macure?

Proper storage of Cloxacillin Macure is essential to ensure the stability and efficacy of the medication. Since this medication is administered in hospital or clinical settings, storage is typically managed by the hospital pharmacy. However, the following storage guidelines should be observed:

• Unopened vials: Store below 25°C (77°F). Keep in the original carton to protect from light and moisture. Do not freeze. Store in a dry place away from direct sunlight and heat sources.
• Reconstituted solution: Once the powder has been dissolved in a suitable diluent, the reconstituted solution should ideally be used immediately. If immediate use is not possible, the reconstituted solution may be stored for up to 24 hours at 2–8°C (refrigerated), depending on the diluent used. Always follow your hospital pharmacy's specific guidance on reconstituted solution stability.
• Infusion solutions: Once further diluted for intravenous infusion (e.g., in sodium chloride 0.9% or glucose 5%), the diluted solution should be used within the timeframe specified by the hospital pharmacy, typically within 4–8 hours at room temperature.
• Expiry date: Do not use Cloxacillin Macure after the expiry date printed on the vial label and outer carton. The expiry date refers to the last day of that month.
• Visual inspection: Before administration, the reconstituted solution should be visually inspected for particulate matter and discoloration. The solution should be clear or slightly opalescent. Do not use if the solution appears turbid, contains visible particles, or has changed color.

Disposal of unused medication or expired vials should follow local regulations for pharmaceutical waste. Do not dispose of medications via household waste or wastewater. In many countries, unused medications can be returned to a pharmacy for safe disposal. Healthcare facilities have specific protocols for the disposal of pharmaceutical waste in accordance with environmental and safety regulations.

What Does Cloxacillin Macure Contain?

Cloxacillin Macure is a single-ingredient pharmaceutical product containing cloxacillin in its sodium salt form. Understanding the composition is important for patients and healthcare providers, particularly for those with specific allergies or dietary restrictions.

Active Ingredient

Each vial contains cloxacillin sodium monohydrate equivalent to 1 g of cloxacillin. Cloxacillin sodium is the water-soluble sodium salt form of cloxacillin, which allows it to be dissolved for injection or infusion. The molecular formula of cloxacillin sodium monohydrate is C₁₉H₁₇ClN₃NaO₅S·H₂O, with a molecular weight of approximately 475.9 g/mol.

Excipients

Cloxacillin Macure powder for solution for injection/infusion typically does not contain additional excipients. The powder consists of cloxacillin sodium monohydrate only. However, the sodium content inherent to the active ingredient should be noted:

• Sodium: Each 1 g vial contains approximately 2.2 mmol (about 50 mg) of sodium. This is relevant for patients on sodium-restricted diets, particularly those with heart failure, hypertension, or renal impairment. If multiple high doses are given daily (e.g., 12 g/day for endocarditis), the total daily sodium intake from cloxacillin alone can be substantial (approximately 600 mg or 26 mmol).

Physical Characteristics

The powder is a white to off-white crystalline powder. When reconstituted with sterile water for injection, it forms a clear to slightly opalescent solution. The reconstituted solution has a pH of approximately 6.0–7.5. The powder is packaged in clear glass vials sealed with a rubber stopper and aluminum cap.